The Discounted Cash Flow (DCF) valuation of Vertex Pharmaceuticals Inc (VRTX) is 363.14 USD. With the latest stock price at 495.26 USD, the upside of Vertex Pharmaceuticals Inc based on DCF is -26.7%.
| Range | Selected | |
| WACC / Discount Rate | 7.7% - 10.2% | 9.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 268.55 - 611.39 | 363.14 |
| Upside | -45.8% - 23.4% | -26.7% |